Subscribe To
Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical Officer
DANBURY, Conn., May 24, 2023 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced Burkhard Blank, MD, has joined the company as Executive Vice President, Research & Development and Chief Medical Officer, effective today. […] The post Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chie...
Read More
Posted: May 24 2023, 12:30
Author Name: forextv
Views: 081466